Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09BA03	TENSIKEY COMPLEX	G	Lisinopril - 20mg, Hydrochlorothiazide - 12.5mg		Tablet	536,193 L.L
G04BE03	TOURNES	G	Sildenafil - 100mg	100mg	Tablet	1,449,961 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 10mg, Hydrochlorothiazide - 12.5mg		Tablet	2,243,577 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	2,189,823 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	49,451,224 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	23,076,914 L.L
R03DB05	THEODEX	G	Ipeca fluide extract - 20mg, Aminophylline - 150mg, Caffeine - 100mg, Ephedrine - 15mg		Tablet	156,142 L.L
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	296,925 L.L
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	154,862 L.L
R05CA12	TOUCALM	G	Dried Ivy leaf extract - 0.7g/100ml	0.7g/100ml	Syrup	300,765 L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
N03AF01	TEGRETOL	B	Carbamazepine - 2%	2%	Suspension	456,906 L.L
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	569,093 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	560,924 L.L
N02BE01	TYLENOL	B	Paracetamol - 100mg	100mg	Suppository	190,826 L.L
N02BE01	TYLENOL	B	Paracetamol - 200mg	200mg	Suppository	235,172 L.L
N02BE01	TYLENOL	B	Paracetamol - 350mg	350mg	Suppository	239,204 L.L
R01AD08	TICANASE	G	Fluticasone propionate - 50mcg/actuation	12g/Bottle	Spray, suspension	405,840 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 0.5mg/ml, Carbocysteine - 5mg/ml		Spray, solution	608,761 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 1mg/ml, Carbocysteine - 10mg/ml		Spray, solution	646,388 L.L
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
B03AE10	TOT'HEMA	B	Copper (gluconate) - 0.70mg/10ml, Manganese (gluconate) - 1.33mg/10ml, Iron (gluconate) - 50mg/10ml		Solution	604,729 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Solution	355,798 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.05%	0.05%	Solution	623,287 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.025%	0.025%	Solution	564,414 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.1%	0.1%	Solution	682,160 L.L
R03BB04	TIOVA-T	G	Tiotropium bromide monohydrate - 18mcg	18mcg	Rotacaps	384,339 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	1,857,190 L.L
D11AX	TRIO-2000	G	Hydroquinone - 4%, Tretinoin - 0.05%, Hydrocortisone acetate - 1%		Ointment	2,495,068 L.L
D06AA04	TETRACYCLINE OINTMENT	G	Tetracycline HCl - 3%	3%	Ointment	107,507 L.L